VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Abbott Laboratories vs Lifco AB (publ)
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Abbott Laboratories
ABT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisLifco AB (publ)
LIFCO-B · Nasdaq Stockholm
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Lifco AB (publ)'s moat claims, evidence, and risks.
View LIFCO-B analysisComparison highlights
- Moat score gap: Abbott Laboratories leads (64 / 100 vs 58 / 100 for Lifco AB (publ)).
- Segment focus: Abbott Laboratories has 7 segments (26.7% in Cardiovascular & Electrophysiology Devices); Lifco AB (publ) has 3 segments (51.2% in Systems Solutions).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Abbott Laboratories has 10 moat types across 3 domains; Lifco AB (publ) has 8 across 2.
Primary market context
Abbott Laboratories
Cardiovascular & Electrophysiology Devices
Cardiovascular, electrophysiology, rhythm management, structural heart and heart failure devices
Global
Hospitals, ambulatory surgery centers, cardiologists/electrophysiologists
Implantable device manufacturer
26.7%
Lifco AB (publ)
Systems Solutions
Niche B2B systems solutions (contract manufacturing, environmental technology, infrastructure products, special products, transportation products)
Primarily Europe; global customers where applicable
B2B OEMs and industrial customers
Niche manufacturer and systems solution provider
51.2%
Side-by-side metrics
Moat coverage
Shared moat types
Abbott Laboratories strengths
Lifco AB (publ) strengths
Segment mix
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Diagnostic Products
Oligopoly
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Diabetes Care (CGM & glucose monitoring)
Duopoly
Cardiovascular & Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
Lifco AB (publ) segments
Full profile >Dental
Oligopoly
Demolition & Tools
Oligopoly
Systems Solutions
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.